Semax 5 mg

Semax is a synthetic heptapeptide corresponding to a modified fragment of adrenocorticotropic hormone, ACTH(4-10), extended with a proline-glycine-proline tail. The peptide is referenced in laboratory literature for its defined structure and stability profile in laboratory handling.

The Semax research compound is being prepared as a 5 mg research-use-only laboratory material. Once batch release is complete, the Semax research peptide will be supplied as a white lyophilised powder in a sterile amber vial with batch-specific documentation.

Batch release, HPLC certification and independent third-party testing are currently in progress. Semax is therefore not yet available to buy, and the stated purity should not be presented as a completed batch result until certification and testing have been finalised.

Semax is not a medicine, supplement or veterinary product, is not licensed by the MHRA for human or animal use, and must not be administered to humans or animals.

NXT GEN RESEARCH is a UK supplier preparing Semax for laboratory research. The planned Semax 5 mg product will be stocked and dispatched from within the United Kingdom following batch release.

Once available, UK orders are intended to be sent using the stated 24-hour tracked service, with delivery listed as 1-3 business days. Pricing is shown in GBP, and institutional buyers can use the institutional account route where invoicing is required.

NXT GEN RESEARCH acts as the product provider and supplier rather than a research contractor. The service covers the supply of research material and its supporting documentation once released. The design and conduct of laboratory research remain outside the product supply service.

Researchers can register an email address now to be notified when the Semax batch has completed the release process and the product becomes available online.

Researchers comparing a Semax provider or supplier should be able to assess the material using specific batch information rather than relying solely on descriptions such as ‘trusted’, ‘reliable’ or ‘affordable’.

For this product, the stated specification includes a target purity of 99%+, a defined batch reference and planned HPLC certification and independent third-party testing for identity and purity. However, the original product information states that batch release, HPLC certification and third-party testing are still in progress.

The current product status should therefore remain clear. The proposed laboratory grade Semax material should only be described using completed testing results once those results and the relevant Certificate of Analysis are available.

The planned 5 mg product contains Semax lyophilised powder supplied in a sterile amber vial. Lyophilisation provides the format specified for this synthetic ACTH(4-10) analogue and its laboratory handling.

Once released, each vial will carry its batch code so the physical research material can be matched with the corresponding batch documentation.

Researchers searching specifically for Semax 5mg can register for an availability notification while batch certification and third-party testing are completed.

The planned Semax 5mg product contains 5 mg of synthetic research peptide in a sterile amber vial. The material is specified as a white lyophilised powder and classified as a synthetic ACTH(4-10) analogue.

Batch SEM-2608-014 is currently undergoing the stated release, HPLC certification and third-party testing processes. The product should not be treated as available stock until those processes have been completed and its status has been updated.

Semax is intended to be available online from NXT GEN RESEARCH exclusively for scientific and laboratory research, but the current 5 mg product has not yet been released for sale.

Laboratories looking to buy Semax online in the UK can currently register for an availability notification rather than place an order. This keeps the distinction clear between a forthcoming ‘Semax for sale’ listing and material that has completed batch release and is ready for laboratory supply.

The listed price is £29.99 for 5 mg. Once released, the published price will allow laboratories to assess whether the product is affordable for their purchasing requirements alongside the completed specification and batch documentation.

The term Laboratory Grade Semax should be supported by the specification and documentation associated with the material rather than used as an unsupported quality claim.

The proposed product specification states 99%+ purity, with HPLC certification and independent third-party testing for identity and purity. These processes are currently in progress for batch SEM-2608-014.

Once the batch has been released, its completed documentation can provide the evidence researchers need to assess the material before ordering.